Literature DB >> 24262390

Recognition of herpes simplex viruses: toll-like receptors and beyond.

Yijie Ma1, Bin He2.   

Abstract

Herpes simplex viruses (HSVs) are human pathogens that establish lytic and latent infections. Reactivation from latency occurs intermittently, which represents a lifelong source of recurrent infection. In this complex process, HSV triggers and neutralizes innate immunity. Therefore, a dynamic equilibrium between HSV and the innate immune system determines the outcome of viral infection. Detection of HSV involves pathogen recognition receptors that include Toll-like receptors, retinoic acid-inducible gene I-like receptors, and cytosolic DNA sensors. Moreover, innate components or pathways exist to sense membrane fusion upon viral entry into host cells. Consequently, this surveillance network activates downstream transcription factors, leading to the induction of type I interferon and inflammatory cytokines. Not surprisingly, with the capacity to establish chronic infection HSV has evolved strategies that modulate or evade innate immunity. In this review, we describe recent advances pertinent to the interplay of HSV and the induction of innate immunity mediated by pathogen recognition receptors or pathways.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Toll-like receptor; cytokine; herpes simplex virus; innate immunity; interferon

Mesh:

Substances:

Year:  2013        PMID: 24262390      PMCID: PMC3943799          DOI: 10.1016/j.jmb.2013.11.012

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  147 in total

1.  Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Authors:  Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  The herpes simplex virus type 1 U(S)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain.

Authors:  Kevin A Cassady; Martin Gross
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection.

Authors:  Kasey M Eidson; William E Hobbs; Brian J Manning; Paul Carlson; Neal A DeLuca
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.

Authors:  Rongtuan Lin; Ryan S Noyce; Susan E Collins; Roger D Everett; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Val193 and Phe195 of the gamma 1 34.5 protein of herpes simplex virus 1 are required for viral resistance to interferon-alpha/beta.

Authors:  G Cheng; M E Brett; B He
Journal:  Virology       Date:  2001-11-10       Impact factor: 3.616

6.  In vivo replication of an ICP34.5 second-site suppressor mutant following corneal infection correlates with in vitro regulation of eIF2 alpha phosphorylation.

Authors:  Stephen L Ward; Donalyn Scheuner; Jeremy Poppers; Randal J Kaufman; Ian Mohr; David A Leib
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Second-site mutation outside of the U(S)10-12 domain of Deltagamma(1)34.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially restores neurovirulence.

Authors:  Kevin A Cassady; Martin Gross; G Yancey Gillespie; Bernard Roizman
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.

Authors:  Jenny A Murphy; Rebecca J Duerst; Tracy J Smith; Lynda A Morrison
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Innate cellular response to virus particle entry requires IRF3 but not virus replication.

Authors:  Susan E Collins; Ryan S Noyce; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.

Authors:  Jennifer Lund; Ayuko Sato; Shizuo Akira; Ruslan Medzhitov; Akiko Iwasaki
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  46 in total

1.  Selective Editing of Herpes Simplex Virus 1 Enables Interferon Induction and Viral Replication That Destroy Malignant Cells.

Authors:  Xing Liu; Bin He
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

Review 2.  The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.

Authors:  Daniel Giraldo; Douglas R Wilcox; Richard Longnecker
Journal:  DNA Cell Biol       Date:  2017-03-09       Impact factor: 3.311

3.  IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.

Authors:  Jameson K Gardner; Melissa M Herbst-Kralovetz
Journal:  Cytokine       Date:  2018-08-15       Impact factor: 3.861

Review 4.  Oncolytic herpes simplex virus interactions with the host immune system.

Authors:  Dipongkor Saha; Hiroaki Wakimoto; Samuel D Rabkin
Journal:  Curr Opin Virol       Date:  2016-08-03       Impact factor: 7.090

5.  The E3 Ubiquitin Ligase TBK1 Mediates the Degradation of Multiple Picornavirus VP3 Proteins by Phosphorylation and Ubiquitination.

Authors:  Dan Li; Wenping Yang; Jingjing Ren; Yi Ru; Keshan Zhang; Shaozu Fu; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

6.  A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation.

Authors:  Jianyun Liu; Richard M Gallo; Carol Duffy; Randy R Brutkiewicz
Journal:  Viral Immunol       Date:  2016-06-21       Impact factor: 2.257

Review 7.  Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Authors:  Ann-Marie Lobo; Alex M Agelidis; Deepak Shukla
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

8.  SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7.

Authors:  Hao Guo; Jialong Zhang; Xuyuan Zhang; Yanbing Wang; Haisheng Yu; Xiangyun Yin; Jingyun Li; Peishuang Du; Joel Plumas; Laurence Chaperot; Jianzhu Chen; Lishan Su; Yongjun Liu; Liguo Zhang
Journal:  J Immunol       Date:  2015-04-10       Impact factor: 5.422

9.  Antiviral innate immunity: editorial overview.

Authors:  Eric O Freed; Michael Gale
Journal:  J Mol Biol       Date:  2014-01-22       Impact factor: 5.469

10.  Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection.

Authors:  Hua Liang; Zhaojun Duan; Dan Li; Dongliang Li; Zheng Wang; Li Ren; Tao Shen; Yiming Shao
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.